Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Shaw Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Battling Blood-Sucking Bugs
      • Unexpected Leads to Curb Addiction
      • Shaping Therapies for Sickle Cell Disease
      • The Mind’s Map Maker
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
The NIH Catalyst: A Publication About NIH Intramural Research

National Institutes of Health • Office of the Director | Volume 23 Issue 4 • July–August 2015

From the Deputy Director for Intramural Research

Long-term Planning at the NIH: The End of the Beginning

BY MICHAEL GOTTESMAN, DDIR

Michael Gottesman

Two years ago, the NIH intramural program began the long process of long-term planning, with a 5-10 year event horizon. This activity was driven by the reality of a 30 percent decline in the purchasing power of intramural funds over the past 10 years, a change in the way in which we conduct science, the need for much more workforce diversity, and a need to provide appropriate funds to maintain the NIH Clinical Center as the preeminent clinical research facility in the world. This lengthy long-term planning process included many consultations with NIH Institute and Centers (IC) directors and scientific directors, individual recommendations from blue ribbon panel committees established in each IC using both intramural and extramural experts, a synthesis of these ideas by the scientific directors, and a report last December 12, 2015, by an external subcommittee of the Advisory Committee to the Director (ACD), co-chaired by Cato Laurencin (University of Connecticut in Storrs) and our Principal Deputy Director, Larry Tabak.

To implement the ACD report, the Office of Intramural Research assembled a response and implementation plan that has been vetted by IC Directors, scientific directors, and an implementation committee consisting of a broad spectrum of tenure-track and tenured intramural scientists, scientific directors, the Assembly of Scientists, and administrative leadership. The hard work of all of these groups led to a document that included 44 specific recommendations that was presented on June 12, 2015, to the ACD where it was enthusiastically received. In consequence, NIH Director Francis Collins has urged us to move ahead with implementation of this long-term plan, which includes many new ideas for ways in which we support and conduct science, and a summary of research areas in which the IRP is perfectly poised to make major advances.

The report addresses four major areas in which change is contemplated:

  1. The NIH Clinical Center (CC) will remain the centerpiece of translational research at the NIH with assured and appropriate funding, more alliances with the neighboring extramural clinical research community, and an enhanced role in training the next generation of physician-scientists, and in developing career tracks for clinical investigators. The CC is a rich repository of phenotypic data on patients with both rare and common diseases, and assuring that genotypic data is obtained on a large cohort of CC subjects is critical to advance genotype-phenotype correlations. The CC will be a referral center for subjects with unusual genotypes where comprehensive phenotyping is essential to understand their biology.
  2. The NIH IRP will become a role model for improving the diversity of the biomedical workforce. We will cast the widest net possible for scientists in all research positions at the NIH, develop new pathways for career development that allow investigators to graduate more quickly to independence, develop a central program for recruitment, mentoring, and career development of postdoctoral fellows, and enhance existing entry-level programs for students from diverse backgrounds.
  3. To become a dynamic research environment for new generations of imaginative scientists, we will encourage trans-NIH recruitments, such as the Stadtman Investigator and NIH-Lasker Clinical Research Scholars program, we will support the careers of staff scientists and clinicians and encourage and reward team science, and create new pathways to independence such as the assistant clinical investigator and a new assistant laboratory investigator position.
  4. NIH will create new pools of funds at the IC level as well as centrally to encourage flexibility of support for new programs and research opportunities. Centrally, these funds will be gradually established as the NIH budget allows, to equal approximately one percent of the NIH intramural budget. These funds will be used to stimulate new initiatives, support new recruitments, and encourage trans-NIH collaborations.

In addition to these process changes, the IC-specific recommendations for areas deserving of research priority led to a set of crosscutting research areas that have been embraced by our scientific leadership and staff. One area of universal interest is the development of a technology incubator at the NIH where new instrumentation for optical exploration of cells, new initiatives in structural biology (i.e., use of cryo-EM for atomic resolution of structures of proteins bound to small molecules), and new clinical imaging modalities could be developed. Such a resource would enable recruitment of talented early-career investigators and provide a sabbatical cradle for nurturing new ideas.

There were nine areas of crosscutting science that are described in more detail as an attachment to the response and implementation plan. These include the study of chronic inflammatory diseases, support of gene- and cell-based therapies, studies on the microbiome and its role in health and disease, drug-resistance studies in microbes and in diseases such as cancer and epilepsy, the neuroscience of compulsive brain behaviors (addictions, obsessive-compulsive, and eating disorders), RNA biology and therapeutics using and targeting RNA, vaccine development, natural products, and the creation of novel animal models. Although these areas are by no means meant to limit basic and clinical research at the NIH, they are judged to be areas of particular promise worthy of additional support and encouragement.

This fall at the 2015 Research Festival, on September 16 to 18, we will highlight these research areas and kick-off the NIH intramural long-term plan. I look forward to seeing you there!


You can find the long-term reports (ACD LT IRP Working Group reports) at http://acd.od.nih.gov/meetings.htm.

This page was last updated on Monday, April 25, 2022

  • Issue Overview
  • Features
    • Cryo-EM Holds Promise for Drug Discovery
    • ROK-Solid Research
    • The Organ Prophet
    • Defending the Honor of the Y Chromosome
  • Departments
    • From the Deputy Director for Intramural Research
    • Colleagues: Recently Tenured
    • New Methods
    • Photographic Moment
    • Research Briefs
    • News You Can Use
    • News Briefs
    • The Training Page
    • The SIG Beat
    • Announcements
  • Issue Contents
  • Download this issue as a PDF

Catalyst menu

  • Current Issue
  • Previous Issues
  • About The NIH Catalyst
  • Contact The NIH Catalyst
  • Share Your Story
  • NIH Abbreviations

Subscribe Today!

Subscribe to The NIH Catalyst Newsletter and receive email updates.

Subscribe

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search